ClinVar Miner

Submissions for variant NM_000143.3(FH):c.965T>G (p.Val322Gly) (rs863224003)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Division of Genomic Diagnostics,The Children's Hospital of Philadelphia RCV000445631 SCV000537250 uncertain significance Multiple cutaneous leiomyomas 2017-01-17 criteria provided, single submitter clinical testing
GeneDx RCV000196089 SCV000251476 likely pathogenic not provided 2018-05-01 criteria provided, single submitter clinical testing This variant is denoted FH c.965T>G at the cDNA level, p.Val322Gly (V322G) at the protein level, and results in the change of a Valine to a Glycine (GTT>GGT). This variant was reported in an individual with papillary type II renal cell carcinoma (Bhola 2018). FH Val322Gly was not observed at a significant allele frequency in large population cohorts (Lek 2016). This variant is located in the core helix (Picaud 2011). In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect. Based on currently available evidence and internal data, we consider FH Val322Gly to be a likely pathogenic variant.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.